A Bi-criterion Approach to Multimodal Optimization: Self-adaptive Approach

Amit Saha,K. Deb

DOI: https://doi.org/10.1007/978-3-642-17298-4_10

2010-12-01

Abstract:

What problem does this paper attempt to address?

Phonological priming reflects lexical competition

M. Hamburger,Louisa M. Slowiaczek

DOI: https://doi.org/10.3758/BF03214558

1996-12-01

Psychonomic Bulletin & Review

Abstract:
CT/MR features of xanthogranulomatous cholecystitis

Wei-wei LI,Ri-sheng YU,Feng CUI

DOI: https://doi.org/10.3969/j.issn.1008-1062.2017.08.009

2017-01-01

Abstract:Objective: The purpose of this study is to discuss the features of xanthogranulomatous cholecystitis (XGC) on CT /MR. Methods: Twenty-eight patients were confirmed XGC by surgery and pathology, and CT/MR manifestations were an-alyzed. Results: On CT or MRI, gallbladder wall thickening was shown in all 28 cases (100%), diffuse thickening was in 22 cases(78.57%), and stones of gallbladder/bile duct were shown in 21 cases(75%), with nodules in gallbladder wall in 10 cases (35.71%), continuous mucosal line enhancement in 25 cases (89.29%), and adjacent structure infiltration in 24 cases (85.71%), respectively. Conclusion: The co-existence of gallbladder wall diffuse thickening, continuous mucosal line enhancement, nod-ules in gallbladder wall and stones of gallbladder/bile duct are characteristics of XGC.
Value of Ultrasonography in Diagnosis of Xanthogranulomatous Cholecystitis

Chunmei Liu,Pintong Huang,Yao Wang,Xu Zhang,Xiangdong You

DOI: https://doi.org/10.3785/j.issn.1008-9292.2017.10.16

2017-01-01

Abstract:OBJECTIVE:To assess the value of ultrasonography in differential diagnosis of xanthogranulomatous cholecystitis (XGC) and wall-thickening type of gallbladder cancer (GBC). METHODS:The clinical features and sonographic finding of 31 patients with XGC and 36 patients with wall-thickening type of GBC were retrospectively reviewed. The diagnosis of all cases was confirmed by pathological examination, and the ultrasonographic manifestations of the thickening of the gallbladder wall, intramural hypoechoic nodules, gallbladder mucosa line, gallbladder stones, biliary dilatation and gallbladder-liver boundary were compared between two groups. RESULTS:There were significant differences in the intramural hypoechoic nodules, the continuous gallbladder wall mucosal line and dilatation of bile duct between XGC and GBC groups (all P<0.05), while no statistically significant differences in the other sonographic features(all P>0.05). In the six positive sonographic features of the XGC patients, the intramural hypoechoic nodules and the continuous mucosa line of the gallbladder wall had highest accuracy in the diagnosis of XGC(64.2% and 65.7%). CONCLUSIONS:Intramural hypoechoic nodule and the continuous mucosal line are characteristic sonographic features of XGC, which can be used for the diagnosis of XGC.
Xanthogranulomatous cholecystitis mimicking advanced gallbladder carcinoma - Analysis of 8 cases

Sabina Khan,Inara Abeer,Musharraf Husain,Mohd Jaseem Hassan,Sujata Jetley

DOI: https://doi.org/10.4103/jcrt.JCRT_1180_19

Abstract:Background/aim: Xanthogranulomatous cholecystitis (XGC) is a rare destructive inflammatory disease of the gallbladder. It is frequently misdiagnosed as gallbladder carcinoma (GBC) as it mimics latter with regard to clinical manifestations, imaging and intraoperative findings, often leading to extended surgical resection in these patients. The aim of this study was to evaluate the diagnostic dilemma of XGC cases clinico-radiologically diagnosed with GBC. Materials and methods: From January 2017 to June 2019, a total of eight cases histopathologically diagnosed as XGC, were misdiagnosed with GBC based on preoperative and intra-operative findings. The clinical characteristics, imaging, intra-operative findings, and surgical data of these patients were collected and analyzed. Results: A total of 2154 cholecystectomy specimens were received in the histopathology section during the study period. Sixty-nine cases (3.2%) were histologically diagnosed as XGC, of which 8 cases (11.6%) were preoperatively diagnosed with GBC. These cases were predominantly seen in males in the age range of 24-62 years. The most common clinical presentation was chronic cholecystitis. Gallstones were present in all the 8 cases. Six cases presented with heterogeneous enhancement within thickened gallbladder walls on imaging. Intraoperatively, adhesions to adjacent organs were observed in seven cases. All these eight cases misdiagnosed with GBC underwent aggressive surgical treatment following which histopathology ultimately revealed XGC. Conclusion: Neither clinical manifestations nor laboratory tests/radiological methods can provide an effective means of differentiating between XGC and GBC. Preoperative diagnosis is difficult, and histopathology remains the gold standard to differentiate the two entities.
Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases

Yi-Lei Deng,Nan-Sheng Cheng,Shui-Jun Zhang,Wen-Jie Ma,Anuj Shrestha,Fu-Yu Li,Fei-Long Xu,Long-Shuan Zhao

DOI: https://doi.org/10.3748/wjg.v21.i44.12653

2015-11-28

Abstract:Aim: To review and evaluate the diagnostic dilemma of xanthogranulomatous cholecystitis (XGC) clinically. Methods: From July 2008 to June 2014, a total of 142 cases of pathologically diagnosed XGC were reviewed at our hospital, among which 42 were misdiagnosed as gallbladder carcinoma (GBC) based on preoperative radiographs and/or intra-operative findings. The clinical characteristics, preoperative imaging, intra-operative findings, frozen section (FS) analysis and surgical procedure data of these patients were collected and analyzed. Results: The most common clinical syndrome in these 42 patients was chronic cholecystitis, followed by acute cholecystitis. Seven (17%) cases presented with mild jaundice without choledocholithiasis. Thirty-five (83%) cases presented with heterogeneous enhancement within thickened gallbladder walls on imaging, and 29 (69%) cases presented with abnormal enhancement in hepatic parenchyma neighboring the gallbladder, which indicated hepatic infiltration. Intra-operatively, adhesions to adjacent organs were observed in 40 (95.2%) cases, including the duodenum, colon and stomach. Thirty cases underwent FS analysis and the remainder did not. The accuracy rate of FS was 93%, and that of surgeon's macroscopic diagnosis was 50%. Six cases were misidentified as GBC by surgeon's macroscopic examination and underwent aggressive surgical treatment. No statistical difference was encountered in the incidence of postoperative complications between total cholecystectomy and subtotal cholecystectomy groups (21% vs 20%, P > 0.05). Conclusion: Neither clinical manifestations and laboratory tests nor radiological methods provide a practical and effective standard in the differential diagnosis between XGC and GBC.
The utility of systemic immune inflammatory index in discriminating between gallbladder cancer and xanthogranulomatous cholecystitis: A single-tertiary center experience

Hilmi Anil Dincer,Omer Cennet,Ahmet Bulent Dogrul

DOI: https://doi.org/10.1097/md.0000000000035805

IF: 1.6

2024-02-10

Medicine

Abstract:Xanthogranulomatous cholecystitis (XGC) is a rare variant of chronic cholecystitis and a benign inflammatory disease with nonspecific symptoms and signs. [ 1 ] The gallbladder wall experiences significant proliferative fibrosis due to the inflammatory reaction, which begins with the phagocytosis of bile pigment by macrophages as a result of extravasation of bile to the gallbladder wall that causes the gallbladder wall to thicken asymmetrically. [ 2 ] XGC accounts for 0.7% to 13.2% of all cholecystitis cases. [ 3 ] Gallbladder carcinoma (GBC) is the most prevalent bile tract malignancy, with an incidence of 0.8 to 1.2%. [ 4 ] It is usually diagnosed at a late stage and associated with a poor prognosis, as it progresses with nonspecific symptoms and is diagnosed mostly incidentally in cholecystectomy specimens. [ 5 ] XGC and GBC share similar symptoms and imaging characteristics. [ 6 ] Thus, differentiating between XGC and GBC is not usually easy, as the severe proliferating fibrosis surrounding the gallbladder and adjacent tissues causes more confusion. [ 6 ] The definitive diagnosis depends on the pathological examination of the cholecystectomy material. Distinguishing GBC from XGC in patients with chronic cholecystitis and making an early diagnosis of GBC using preoperative clinical, laboratory, and/or imaging approaches may be helpful for the patients survival and prognosis and choosing the best surgical approach. It is important to have a noninvasive preoperative diagnostic method to distinguish between the 2 diseases.

medicine, general & internal
Xanthogranulomatous Cholecystitis Masquerading as Gallbladder Cancer: Can It Be Diagnosed Preoperatively?

Ashwin Rammohan,Sathya D. Cherukuri,Jeswanth Sathyanesan,Ravichandran Palaniappan,Manoharan Govindan

DOI: https://doi.org/10.1155/2014/253645

IF: 2

2014-01-01

Gastroenterology Research and Practice

Abstract:Background . Xanthogranulomatous cholecystitis (XGC) is often misdiagnosed as gallbladder cancer (GBC). We aimed to determine the preoperative characteristics that could potentially aid in an accurate diagnosis of XGC masquerading as GBC. Methods . An analysis of patients operated upon with a preoperative diagnosis of GBC between January 2008 and December 2012 was conducted to determine the clinical and radiological features which could assist in a preoperative diagnosis of XGC. Results . Out of 77 patients who underwent radical cholecystectomy, 16 were reported as XGC on final histopathology (Group A), while 60 were GBC (Group B). The incidences of abdominal pain, cholelithiasis, choledocholithiasis, and acute cholecystitis were significantly higher in Group A, while anorexia and weight loss were higher in Group B. On CT, diffuse gallbladder wall thickening, continuous mucosal line enhancement, and submucosal hypoattenuated nodules were significant findings in Group A. CT findings on retrospect revealed at least one of these findings in 68.7% of the cases. Conclusion . Differentiating XGC from GBC is difficult, and a definitive diagnosis still necessitates a histopathological examination. An accurate preoperative diagnosis requires an integrated review of clinical and characteristic radiological features, the presence of which may help avoid radical resection and avoidable morbidity in selected cases.

gastroenterology & hepatology
Diminutive metoposaurid skulls from the Upper Triassic Blue Hills (Adamanian:latest Carnian) of Arizona

A. Heckert

Abstract:We describe two tiny metoposaurid specimens from the lower part of the Chinle Group in the Blue Hills of east-central Arizona. The more complete of these specimens is an incomplete skull anterior to the orbits (45 mm preorbitallength) and numerous skull roof and palate fragments. The less complete specimen is a 25-mm-long skull roof fragment surrounding the left orbit. Based on the sutural relationships of the skull bones anterior to the orbit, we identify the more complete specimen as a juvenile of Buettneria perfecta Case, 1922 and tentatively identify the less complete specimen as Apachesaurus gregorii Hunt, 1993. These fossils are particularly important because they indicate that cranial sutures do not change significantly during metoposaurid ontogeny.
CT and MR features of xanthogranulomatous cholecystitis: an analysis of consecutive 49 cases.

Feng Zhao,Pu-Xuan Lu,Sen-Xiang Yan,Gao-Feng Wang,Jing Yuan,Shi-Zheng Zhang,Yi-Xiang J Wang

DOI: https://doi.org/10.1016/j.ejrad.2013.04.026

IF: 4.531

2013-01-01

European Journal of Radiology

Abstract:To study the CT and MR features of xanthogranulomatous cholecystitis (XGC).49 patients had pathologically confirmed XGC. All patients underwent contrast enhanced CT, and 10 patients had additional plain MRI. The CT and MRI results were retrospectively analyzed.On CT, all patients had thickening of gallbladder wall, with 87.8% cases showed diffuse thickening. 85.7% cases had intramural hypo-attenuated nodules in the thickened wall. Continuous mucosal line and luminal surface enhancement were noted in 79.6% and 85.7% cases, respectively. Gallbladder stones were seen in 69.4% patients. The coexistence of the above 5 CT features was seen in 40% cases, and 80% cases had the coexistence of ≥ 4 features. Diffused gallbladder wall thickening in XGC is more likely to have disrupted mucosal line, and XGC with disrupted mucosal line is more likely to be associated with liver infiltration. In 60% patients the inflammatory process extended beyond gallbladder, with the interface between gallbladder and liver and/or the surrounding fat blurred. 40% cases had an early enhancement of liver parenchyma. Infiltration to other surrounding tissues included bowel (n=3), stomach (n=2), and abdominal wall (n=1). On MR images, 7 of 9 intramural nodules in 7 subjects with T1-weighted dual echo MR images showed higher signal intensity on in-phase images than out-of-phase images.Coexisting of diffuse gallbladder wall thickening, hypo-attenuated intramural nodules, continuous mucosal line, luminal surface enhancement, and gallbladder stone highly suggest XGC. XGC frequently infiltrate liver and surrounding fat. Chemical-shift MRI helps classifying intramural nodules in the gallbladder wall.
Machine learning-based diagnostic model for preoperative differentiation between xanthogranulomatous cholecystitis and gallbladder carcinoma: a multicenter retrospective cohort study

Tianwei Fu,Yating Bao,Zhihan Zhong,Zhenyu Gao,Taiwei Ye,Chengwu Zhang,Huang Jing,Zunqiang Xiao

DOI: https://doi.org/10.3389/fonc.2024.1355927

IF: 4.7

2024-02-28

Frontiers in Oncology

Abstract:Background: Xanthogranulomatous cholecystitis (XGC) and gallbladder carcinoma (GBC) share similar imaging and serological profiles, posing significant challenges in accurate preoperative diagnosis. This study aimed to identify reliable indicators and develop a predictive model to differentiate between XGC and GBC. Methods: This retrospective study involved 436 patients from Zhejiang Provincial People's Hospital and The Affiliated Lihuili Hospital of Ningbo University. Comprehensive preoperative imaging, including ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and blood tests, were analyzed. Machine learning (Random Forest method) was employed for variable selection, and a multivariate logistic regression analysis was used to construct a nomogram for predicting GBC. Statistical analyses were performed using SPSS and RStudio software. Results: The study identified gender, Murphy's sign, absolute neutrophil count, glutamyl transpeptidase level, carcinoembryonic antigen level, and comprehensive imaging diagnosis as potential risk factors for GBC. A nomogram incorporating these factors demonstrated high predictive accuracy for GBC, outperforming individual or combined traditional diagnostic methods. External validation of the nomogram showed consistent results. Conclusion: The study successfully developed a predictive nomogram for distinguishing GBC from XGC with high accuracy. This model, integrating multiple clinical and imaging indicators, offers a valuable tool for clinicians in making informed diagnostic decisions. The findings advocate for the use of comprehensive preoperative evaluations combined with advanced analytical tools to improve diagnostic accuracy in complex medical conditions.

oncology
Clonal dominance of low‐affinity antibodies in rabbit hyperimmune anti‐streptococcal group A‐variant polysaccharide antisera

W. Schaich,J. Wright,L. Rodkey,D. Braun

DOI: https://doi.org/10.1002/eji.1830090210

1979-02-01

European Journal of Immunology

Abstract:Intraveneous hyperimmunization of selectively bred rabbits with streptococcal group A‐variant vaccines elicits antibody responses of restricted heterogeneity at high antibody levels. In these antisera, IgG with dissociation constants KD = 10−6 M constitutes 90% and IgG with KD = 10−9 M accounts for only 10% of the group A‐variant polysaccharide‐specific antibodies. The low affinity antibody fraction represents the dominant clonotypes. Preparative isoelectric focusing in granulated (Ultrodex G‐75) gels was used to successfully purify single‐band material belonging to dominant spectrotypes. Affinity studies with these antibody fractions with the highest reported degree of purity yielded KD = 10−6 M values, thus confirming that clonal dominance is exclusively associated with low‐affinity antibodies. Since it is known from previous work (M. Cramer and D. G. Braun, Scand. J. Immunol. 1975. 4: 63) and from the rabbit antisera used here that clonal dominance of this sort is long‐lived, this work fails to support the argument of immune maturation. The data more logically relate to antibodies that emerge with different subspecificities ‐ recognized in the antigen as a function of time in immunization procedures — rather than to an inherent property of the immune system.
Participants’ evaluation of a brief intervention for pain-related work disability

Debra A. Dunstan

DOI: https://doi.org/10.1097/MRR.0000000000000069

2014-12-01

Abstract:The aim of the study was to describe participants’ evaluation of a light cognitive-behavioral therapy-based intervention for pain-related work disability. The sample (n=33) participated in a 6-week program and had the following features: mean age was 41 years; 67% men; 54.5% back injury; 48.5% unskilled; and mean time lost from work was 16.6 months (range 2–161 months). A program evaluation form was completed. The program was reportedly helpful for improving pain self-management, activity levels, and work resumption. However, over 25% of the sample requested more time be spent on sleep strategies, relaxation, and anger and flare-ups management. It ‘did not solve the pain problem’. Despite making gains in pain management, many participants continued to experience pain and desired to sleep better, relax more, and be distress and pain free. This ongoing suffering may be under recognized in a system that focuses on return-to-work before full recovery.
Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer

Xiaobo Bo,Erbao Chen,Jie Wang,Lingxi Nan,Yanlei Xin,Changchen Wang,Qing Lu,Shengxiang Rao,Lifang Pang,Min Li,Pinxiang Lu,Dexiang Zhang,Houbao Liu,Yueqi Wang

DOI: https://doi.org/10.21037/atm.2019.11.35

IF: 3.616

2019-01-01

Annals of Translational Medicine

Abstract:Background: The aim of this study was to assess the diagnostic performance of radiological imaging in differentiating xanthogranulomatous cholecystitis (XGC) from gallbladder cancer (GBC). Methods: A retrospective analysis of the radiological imaging performed in patients who had pathologically confirmed XGC or GBC between December 2004 to April 2016 was performed. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of each imaging modality, and combined imaging modalities were calculated. Results: A total of 218 patients (XGC = 109, GBC = 109) were identified; 19 patients received all of abdominal ultrasound (US), contrast-enhanced ultrasound (CEUS), computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography-computed tomography (PET/CT); 21 received four of these imaging examination types; 45 received three examinations; 58 received two examinations; and 75 received only one examination. The sensitivity and specificity of CEUS was 90% and 93%, respectively, higher than abdominal US (80%, 86%), CT (71%, 92%), MRI (75%, 90%), and PET/CT (55%, 90%) (all values respective). The sensitivity, specificity, NPV, and PPV of the US combined with CEUS were 91%, 90%, 94%, and 85%, respectively. Although the specificity of CEUS + CT and CEUS + MRI were 100% and 92%, respectively, the sensitivity of CEUS + CT and CEUS + MRI were both only 67%. Conclusions: The Abdominal US is not sufficiently accurate to confidently guide clinical practice, and CEUS showed better diagnostic performance than the other imaging modalities in differentiating XGC from GBC. The combination of abdominal CEUS and CT is helpful for differential diagnosis, as it indicates GBC with better specificity and PPV.
[Make still further progress].

J. Lang

2005-05-01

Abstract:
Xanthogranulomatous Cholecystitis: A Retrospective Review of Clinical Diagnosis and Treatment from a Single Center

Mehmet Torun,Cebrail Akyüz,Deniz Kol,Mehmet Ali Özbay

DOI: https://doi.org/10.3390/healthcare12212184

2024-11-02

Health Care

Abstract:The objective of this study was to evaluate and compare the histopathological, clinical, and treatment characteristics of xanthogranulomatous cholecystitis (XGC) in patients undergoing cholecystectomy at a single center. Aim: We aim to enhance the understanding of its presentation and improve its differential diagnosis from other gallbladder pathologies. Methods: We retrospectively reviewed 6783 cholecystectomy cases performed between January 2015 and January 2023 at the General Surgery Clinic of Haydarpaşa Numune Training and Research Hospital, and a diagnosis of xanthogranulomatous cholecystitis was histopathologically established in 131 patients. In this retrospective study, we examined the clinicopathological characteristics, preoperative imaging methods and findings, histopathological images, surgical procedure methods, and postoperative complications of 131 patients. Results: The study included 131 patients, with ages ranging from 18 to 88 years, of which 74 (56.5%) were female and 57 (43.5%) were male. Ultrasound imaging was performed on 128 patients. Ultrasound imaging revealed wall thickening in 72.7% of cases, hypoechoic nodules in 13.3%, biliary tract pathologies in 10.9%, and adenomyomatosis in 3.1%. A total of 59 cases had MRI. On MRI, wall thickening was observed in 50.8% of cases, biliary tract pathologies in 33.9%, adenomyomatosis in 10.2%, hypoechoic nodules in 3.4%, and hypoechoic nodules + wall thickening (HN + WT) in 1.7%. Histopathological diagnosis was diffuse in 79.4% of cases and focal in 20.6%. In addition to cholecystectomy, non-surgical interventions were not required in 77.1% of the cases, while 11.5% underwent ERCP, 9.2% underwent percutaneous procedures, 1.5% underwent both ERCP and percutaneous procedures, and 0.8% underwent other non-surgical interventions. Of the surgeries, 93.1% were elective and 6.9% were emergency. Postoperative complications were not observed in 84% of the patients; 5.3% experienced surgical complications, 5.3% had surgical site infection, and 5.3% had other complications (pneumonia and urinary infection). The length of hospital stay ranged from 0 to 26 days, with a mean of 5.27 ± 4.59 days and a median of 4 days. Conclusions: Xanthogranulomatous cholecystitis is a rare disease of the gallbladder with no characteristic radiological or clinical findings and can often be confused with gallbladder cancer. Further studies involving larger populations are needed to improve the preoperative diagnosis.

health care sciences & services,health policy & services
Development of a Reduction‐Responsive Amino Acid that Induces Peptide Bond Cleavage in Hypoxic Cells

Akira Shigenaga,K. Ogura,H. Hirakawa,Jun Yamamoto,Koji Ebisuno,Licht Miyamoto,K. Ishizawa,K. Tsuchiya,A. Otaka

DOI: https://doi.org/10.1002/cbic.201200141

IF: 3.2

2012-05-07

ChemBioChem

Abstract:Hypoxia-responsive amino acids are indispensable in the preparation of hypoxic tumor-specific peptidyl prodrugs. In this paper, the design and synthesis of a reduction-responsive amino acid that induces peptide bond cleavage after reduction of the nitro group are described. Application to hypoxia-responsive peptide bond cleavage system is also reported.
Aldesleukin in advanced renal cell carcinoma

M. Schmidinger,M. Hejna,C. Zielinski

DOI: https://doi.org/10.1586/14737140.4.6.957

2004-12-01

Expert Review of Anticancer Therapy

Abstract:Renal cell carcinoma accounts for 2–3% of all malignancies. The most common subtype [85%] is the clear cell variant. A total of 30% of patients present with metastatic disease at diagnosis and another 30–40% will develop metastases during the course of the disease. Conventional cancer treatment is not effective, but cytokines including recombinant interleukin-2 (aldesleukin) have demonstrated clinical activity of various degrees. This drug profile provides a review of the literature on studies using aldesleukin in patients with metastatic renal cell carcinoma. Aldesleukin has been used in different dose schedules applying various administration routes, as either monotherapy or in combination with other cytokines, chemotherapy, endocrine treatment and adoptive cellular immunotherapy. Although a large number of randomized trials have been performed with different treatment strategies, it still remains uncertain whether the dose or combination of aldesleukin with other agents substantially influence treatment outcome. It appears that factors other than those that are treatment related are responsible for the course of the disease.
Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer.

Ling-Fu Zhang,Chun-Sheng Hou,Jian-Yu Liu,Dian-Rong Xiu,Zhi Xu,Li-Xin Wang,Xiao-Feng Ling

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2012.01.020

IF: 6.133

2012-01-01

Chinese Medical Journal

Abstract:Background Patients with xanthogranulomatous cholecystitis sometimes exhibit imaging and intraoperative findings that are similar to those of advanced gallbladder cancer, thus these patients are easily misdiagnosed. The present study aimed to investigate the characteristics of xanthogranulomatous cholecystitis masquerading as gallbladder cancer that could potentially aid in the correct diagnosis of this condition. Methods The clinical, serological, radiological and operative features of twelve patients with obviously wall-thickening or mass-forming xanthogranulomatous cholecystitis were retrospectively analyzed. Additionally, the patient preoperative features were compared to those of 36 patients with advanced gallbladder cancers. Results Twelve patients with xanthogranulomatous cholecystitis exhibited one to three episodes of acute cholecystitis within 0.5 to 7 months prior to admission to the hospital. Five of these patients exhibited concomitant choledocholithiasis, whereas no concomitant choledocholithiasis was identified in patients with advanced gallbladder cancer. The incidence of abdominal pain (chi(2)=6.588, P=0.010), acute cholecystitis (chi(2)=29.176, P=0.000), acute cholangitis (chi(2)=6.349, P=0.012), choledocholithiasis (chi(2)=16.744, P=0.000), carcinoembryonic antigen test (P=0.007), CA125 (P=0.001), and diffuse gallbladder wall thickening (chi(2)=6.031, P=0.014), continued mucosal line (chi(2)=15.745, P=0.000), homogeneous enhancement of mucosal line (chi(2)=19.947, P=0.000), submucosal hypoattenuated nodules or band (chi(2)=18.607, P=0.000) in computed tomography demonstrated statistically significant differences between cases of xanthogranulomatous cholecystitis and gallbladder cancer. Furthermore, all the twelve patients with xanthogranulomatous cholecystitis exhibited at least one positive computed tomography imaging feature aside from past acute cholecystitis episode, and no patient with advanced gallbladder cancer simultaneously exhibited past acute cholecystitis episode and at least one positive computed tomography imaging feature. Conclusions The accurate preoperative diagnosis of xanthogranulomatous cholecystitis includes an integrated review of past acute cholecystitis episode, choledocholithiasis, and positive computed tomography imaging features. Besides, we present an algorithm for intraoperative diagnosis. Chin Med J 2012;125(1):109-113
Xanthogranulomatous Cholecystitis and Gallbladder Cancer: Two Diseases with Difficult Differential Diagnoses

Gökhan Akkurt,Birkan Birben,Serdar Çoban,Özgür Akgül,Sezer Kulaçoğlu,Mutlu Doğanay

DOI: https://doi.org/10.5152/tjg.2021.201006

Abstract:Background: Xanthogranulomatous cholecystitis (XGC) etiology has not yet been precisely determined; it is often confused with gallbladder cancer (GBC) in the differential diagnosis. Methods: This study retrospectively evaluated patients who underwent surgery with the pre-diagnosis of cholelithiasis, cholecystitis, or gallbladder carcinoma at a tertiary center, and were confirmed to have XGC or GBC according to the histological examinations. Results: In the GBC group, there was a higher number of female patients, patients with magnetic resonance imaging (MRI) and computed tomography (CT) imaging, those that directly underwent open surgery, and those requiring catheters and developed complications; while in the XGC group, there was a higher number of patients with ultrasonography (USG) imaging and those requiring conversion from laparoscopic to open surgery (P < .05). The rate of patients with a preoperative diagnosis of cholelithiasis was higher in the XGC group than in the GBC group, and cases with intrahepatic bile duct (IHBD) dilatation were higher in the GBC group than in the XGC group, and the GBC group also had a higher rate of cases with a malignant diagnosis in the preoperative examination compared to the XGC group (P < .05). Conclusion: When a suspicious malignant mass is detected in the localization of the gallbladder, XGC must be considered in the differential diagnosis. Although it is not a malignant pathology, early diagnosis and treatment are particularly important due to the associated complications and the possibility of coexistence with GBC.
A case of xanthogranulomatous cholecystitis suspected to be adenocarcinoma based on the intraoperative peritoneal washing cytology

Takamichi Ishii,Etsuro Hatano,Kentaro Yasuchika,Kojiro Taura,Hiroyuki Shirahase,Hironori Haga,Shinji Uemoto

DOI: https://doi.org/10.1016/j.ijscr.2014.01.011

Abstract:Introduction: Xanthogranulomatous cholecystitis (XGC) is a variant of chronic cholecystitis. XGC remains difficult to distinguish from gallbladder cancer radiologically and macroscopically. Presentation of case: A 63-year-old female was referred to our hospital because of a gallbladder tumor. Abdominal CT and MRI revealed a thickened gallbladder that had an obscure border with the transverse colon. FDG-PET showed a high uptake of FDG in the gallbladder. Therefore, under the preoperative diagnosis of an advanced gallbladder cancer with invasion to the transverse colon, a laparotomy was performed. Because adenocarcinoma was suspected based on the intraoperative peritoneal washing cytology (IPWC), cholecystectomy and partial transverse colectomy were performed instead of radial surgery. However, the case was proven to be XGC with no malignant cells after the operation. Discussion: In patients with gallbladder cancer who underwent surgery in our institute from 2000 to 2009, the prognosis after the operation of patients with only positive IPWC tended to be better than that of patients with definitive peritoneal disseminated nodules. It is true that in some cases, it is difficult to differentiate XGC from gallbladder carcinoma pre- and intra-operatively. Conclusion: Surgical procedures should be selected based on the facts that there are long-term survivors with gallbladder cancer diagnosed with positive IPWC, and that some patients with XGC are initially diagnosed to have carcinoma by IPWC, as was seen in our case.

A Bi-criterion Approach to Multimodal Optimization: Self-adaptive Approach

Phonological priming reflects lexical competition

CT/MR features of xanthogranulomatous cholecystitis

Value of Ultrasonography in Diagnosis of Xanthogranulomatous Cholecystitis

Xanthogranulomatous cholecystitis mimicking advanced gallbladder carcinoma - Analysis of 8 cases

Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases

The utility of systemic immune inflammatory index in discriminating between gallbladder cancer and xanthogranulomatous cholecystitis: A single-tertiary center experience

Xanthogranulomatous Cholecystitis Masquerading as Gallbladder Cancer: Can It Be Diagnosed Preoperatively?

Diminutive metoposaurid skulls from the Upper Triassic Blue Hills (Adamanian:latest Carnian) of Arizona

CT and MR features of xanthogranulomatous cholecystitis: an analysis of consecutive 49 cases.

Machine learning-based diagnostic model for preoperative differentiation between xanthogranulomatous cholecystitis and gallbladder carcinoma: a multicenter retrospective cohort study

Clonal dominance of low‐affinity antibodies in rabbit hyperimmune anti‐streptococcal group A‐variant polysaccharide antisera

Participants’ evaluation of a brief intervention for pain-related work disability

Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer

[Make still further progress].

Xanthogranulomatous Cholecystitis: A Retrospective Review of Clinical Diagnosis and Treatment from a Single Center

Development of a Reduction‐Responsive Amino Acid that Induces Peptide Bond Cleavage in Hypoxic Cells

Aldesleukin in advanced renal cell carcinoma

Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer.

Xanthogranulomatous Cholecystitis and Gallbladder Cancer: Two Diseases with Difficult Differential Diagnoses

A case of xanthogranulomatous cholecystitis suspected to be adenocarcinoma based on the intraoperative peritoneal washing cytology